HIGHLIGHTS
- who: Suping Tang from the Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China have published the Article: PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma, in the Journal: (JOURNAL)
- what: The study showed that the expression of PAFAH1B3 was upregulated in tissues and cells compared with noncancerous tissues and cells. The authors aimed to demonstrate the correlations between the PAFAH1B3 expression level and clinicopathological parameters and to confirm the potential of PAFAH1B3 as a prognostic biomarker in LUAD patients. The analysis showed that the infiltration score . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.